Your browser doesn't support javascript.
loading
Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education.
Kilbride, Madison; Egleston, Brian L; Chung, Wendy K; Olopade, Olufunmilayo; Maxwell, Kara N; Shah, Payal; Churpek, Jane E; Fleisher, Linda; Terry, Mary Beth; Fetzer, Dominique; Gaieski, Jill Bennett; Bulafka, Jessica; Espinal, Aileen; Karpink, Kelsey; Walser, Sarah; Singleton, Davone; Palese, Monica; Siljander, Ilona; Brandt, Amanda; Clark, Dana; Koval, Carrie; Wynn, Julia; Long, Jessica M; McKenna, Danielle; Powers, Jacquelyn; Nielsen, Sarah; Domchek, Susan M; Nathanson, Katherine L; Bradbury, Angela R.
Affiliation
  • Kilbride M; Department of Philosophy, University of Utah, Salt Lake City, UT.
  • Egleston BL; Fox Chase Cancer Center, Temple University, Philadelphia, PA.
  • Chung WK; Department of Pediatrics and Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York City, NY.
  • Olopade O; The University of Chicago, Chicago, IL.
  • Maxwell KN; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Shah P; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Churpek JE; The University of Chicago, Chicago, IL.
  • Fleisher L; Fox Chase Cancer Center, Temple University, Philadelphia, PA.
  • Terry MB; Herbert Irving Comprehensive Cancer Center and the Mailman School of Public Health, Columbia University Irving Medical Center, New York City, NY.
  • Fetzer D; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Gaieski JB; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Bulafka J; Herbert Irving Comprehensive Cancer Center and the Mailman School of Public Health, Columbia University Irving Medical Center, New York City, NY.
  • Espinal A; Herbert Irving Comprehensive Cancer Center and the Mailman School of Public Health, Columbia University Irving Medical Center, New York City, NY.
  • Karpink K; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Walser S; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Singleton D; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Palese M; The University of Chicago, Chicago, IL.
  • Siljander I; The University of Chicago, Chicago, IL.
  • Brandt A; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Clark D; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Koval C; Department of Pediatrics, Columbia University Irving Medical Center, New York City, NY.
  • Wynn J; Department of Pediatrics, Columbia University, New York City, NY.
  • Long JM; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • McKenna D; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Powers J; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Nielsen S; The University of Chicago, Chicago, IL.
  • Domchek SM; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
  • Nathanson KL; Division of Translational Medicine and Human Genetics, The University of Pennsylvania, Philadelphia, PA.
  • Bradbury AR; Division of Hematology-Oncology, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA.
J Clin Oncol ; 41(31): 4905-4915, 2023 11 01.
Article in En | MEDLINE | ID: mdl-37611220
PURPOSE: We developed a web-based education intervention as an alternative to predisclosure education with a genetic counselor (GC) to reduce participant burden and provider costs with return of genetic research results. METHODS: Women at three sites who participated in 11 gene discovery research studies were contacted to consider receiving cancer genetic research results. Participants could complete predisclosure education through web education or with a GC. Outcomes included uptake of research results, factors associated with uptake, and patient-reported outcomes. RESULTS: Of 819 participants, 178 actively (21.7%) and 167 passively (20.4%) declined return of results; 474 (57.9%) were enrolled. Most (60.3%) received results although this was lower than the 70% uptake we hypothesized. Passive and active decliners were more likely to be Black, to have less education, and to have not received phone follow-up after the invitation letter. Most participants selected web education (88.5%) as an alternative to speaking with a GC, but some did not complete or receive results. Knowledge increased significantly from baseline to other time points with no significant differences between those who received web versus GC education. There were no significant increases in distress between web and GC education. CONCLUSION: Interest in web-based predisclosure education for return of genetic research results was high although it did not increase uptake of results. We found no negative patient-reported outcomes with web education, suggesting that it is a viable alternative delivery model for reducing burdens and costs of returning genetic research results. Attention to attrition and lower uptake of results among Black participants and those with less formal education are important areas for future research.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Telephone / Patient Reported Outcome Measures Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: J Clin Oncol Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Telephone / Patient Reported Outcome Measures Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: J Clin Oncol Year: 2023 Type: Article